锁孔夹闭术治疗非衰弱老年未破裂颅内动脉瘤的有效性验证
本研究比较非衰弱老年(≥70岁)与非老年患者接受锁孔夹闭术治疗相对较小(≤10 mm)前循环未破裂颅内动脉瘤的并发症及临床与影像学结局。结果显示老年组并发症、死亡率、致残率、住院时间及动脉瘤复发率均未显著增加,且焦虑与抑郁改善。作者认为锁孔夹闭术对非衰弱老年患者是有效且持久的治疗。
要点
- 非衰弱老年组(≥70岁)锁孔夹闭术后3个月和1年致残率分别为1.6%和4.8%,与非老年组(2.0%和1.5%)无显著差异。
- 老年组慢性硬膜下血肿发生率8.1%,非老年组4.5%,差异无统计学意义(p=0.332)。
- 两组均无患者死亡,老年组无患者需要再治疗或出现夹闭动脉瘤复发。
核心结论
- 锁孔夹闭术治疗非衰弱老年患者相对较小前循环未破裂颅内动脉瘤,与非老年患者相比未显著增加并发症、死亡率、致残率、住院时间或动脉瘤复发率,且与焦虑和抑郁改善相关。
- 作者认为锁孔夹闭术治疗非衰弱老年未破裂颅内动脉瘤是有效且持久的治疗。
研究设计与样本
- 本研究比较非衰弱老年患者(≥70岁)与非老年患者接受锁孔夹闭术(眶上或翼点入路)治疗260例相对较小(≤10 mm)前循环未破裂颅内动脉瘤的并发症及临床与影像学结局。
- 非衰弱老年组62例(平均年龄72.9±2.6岁),非老年组198例(平均年龄59.5±7.6岁)。
- 评估术后3个月和1年死亡率与致残率(改良Rankin量表评分>2或简易精神状态检查[MMSE]评分<24)、3个月和1年MMSE评估的一般认知功能、3个月贝克抑郁量表(BDI)和汉密尔顿抑郁评定量表(HAM-D)评估的焦虑与抑郁,以及1年影像学异常和复发。
主要发现
- 两组基础特征包括合并症、衰弱、BDI和HAM-D评分无显著差异,而老年组MMSE评分稍低但显著。
- 动脉瘤位置、最大直径、锁孔手术类型、夹闭率及住院时间两组无显著差异。
- 慢性硬膜下血肿发生率老年组8.1% vs 非老年组4.5%(p=0.332),差异无统计学意义;其他并发症包括卒中和癫痫发生率无显著差异。
- 腔隙性梗死发生于老年组3.2%和非老年组3.0%;老年组无患者需要再治疗或出现夹闭动脉瘤复发。
- 非老年组3个月MMSE评分显著改善,老年组无变化;两组3个月BDI和HAM-D评分均显著改善;两组均无患者死亡。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE Advanced age is known to be associated with a poor prognosis after surgical clipping of unruptured intracranial aneurysms (UIAs). Keyhole clipping techniques have been introduced for less invasive treatment of UIAs. In this study, the authors compared the complications and clinical and radiological outcomes after keyhole clipping between nonfrail elderly patients (≥ 70 years) and nonelderly patients. METHODS Keyhole clipping (either supraorbital or pterional) was performed to treat 260 cases of relatively small (≤ 10 mm) anterior circulation UIAs. There were 62 cases in the nonfrail elderly group (mean age 72.9 ± 2.6 years [± SD]) and 198 cases in the nonelderly group (mean age 59.5 ± 7.6 years). The authors evaluated mortality and morbidity (modified Rankin Scale score > 2 or Mini-Mental State Examination [MMSE] score < 24) at 3 months and 1 year after the operation, the general cognitive function by MMSE at 3 months and 1 year, anxiety and depression by the Beck Depression Inventory (BDI) and Hamilton Rating Scale for Depression (HAM-D) at 3 months, and radiological abnormalities and recurrence at 1 year. RESULTS Basic characteristics including comorbidities, frailty, and BDI and HAM-D scores were not significantly different between the 2 groups, whereas the MMSE score was slightly but significantly lower in the elderly group. Aneurysm location, largest diameter, type of keyhole surgery, neck clipping rate, and hospitalization period were not significantly different between the 2 groups. The incidence of chronic subdural hematoma was not significantly higher in the elderly group than in the nonelderly group (8.1% vs 4.5%, p = 0.332); rates of other complications including stroke and epilepsy were not significantly different. Lacunar infarction occurred in 3.2% of the elderly group and 3.0% of the nonelderly group. No patient in the elderly group required re-treatment or demonstrated recurrence of clipped aneurysms. The MMSE score at 3 months significantly improved in the nonelderly group but did not change in the elderly group. The BDI and HAM-D scores at 3 months were significantly improved in both groups. No patient died in either group. The morbidity at 3 months and 1 year in the elderly group (1.6% and 4.8%, respectively) was not significantly different from that in the nonelderly group (2.0% and 1.5%, respectively). CONCLUSIONS Keyhole clipping for nonfrail elderly patients with relatively small anterior circulation UIAs did not significantly increase the complication, mortality, or morbidity rate; hospitalization period; or aneurysm recurrence compared with nonelderly patients, and it was associated with improvement in anxiety and depression. Keyhole clipping to treat UIAs in the nonfrail elderly is an effective and long-lasting treatment.
引用
- Mori K, Wada K, Otani N, et al. Validation of effectiveness of keyhole clipping in nonfrail elderly patients with unruptured intracranial aneurysms. J Neurosurg. 2017. PMID: 28059648. doi:10.3171/2016.9.JNS161634
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。